Recently, our group found that the number of circulating mesenchymal-like cells (CD34−/CD105+) is significantly decreased in type 2 diabetes mellitus (T2DM) patients and is negatively correlated with the progression of chronic diabetic complications [8]. This evidence concerns the gene CD34 and type 2 diabetes mellitus.